ID: ALA4875291

Max Phase: Preclinical

Molecular Formula: C31H22FN3O4

Molecular Weight: 519.53

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2ccc(OCc3ccccc3)c(F)c2)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O

Standard InChI:  InChI=1S/C31H22FN3O4/c1-38-26-12-10-21(22-11-13-27(25(32)16-22)39-18-19-6-3-2-4-7-19)15-24(26)28-29(31(37)35-30(28)36)34-23-9-5-8-20(14-23)17-33/h2-16H,18H2,1H3,(H2,34,35,36,37)

Standard InChI Key:  CCACBAPOIYADMO-UHFFFAOYSA-N

Associated Targets(Human)

Serine/threonine-protein kinase 2 1640 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase 10 2119 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 519.53Molecular Weight (Monoisotopic): 519.1594AlogP: 5.43#Rotatable Bonds: 8
Polar Surface Area: 100.45Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.68CX Basic pKa: CX LogP: 5.00CX LogD: 5.00
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -0.83

References

1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM..  (2021)  Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold.,  64  (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579]

Source